SARS News and Research

RSS

Researchers examine benefits of lateral flow testing with regards to the new Paxlovid drug for treatment of COVID-19

In a new study, researchers from Harvard University explored the benefits of different COVID-19 testing schemes with regards to the new Paxlovid drug.

24 Jan 2022

Study explains why Omicron infections are less likely to cause severe disease

A new study by researchers from the University of Kent and the Goethe University Frankfurt shows that the SARS-CoV-2 Omicron variant is less effective than Delta at blocking a cellular defense mechanism against viruses, the so-called “interferon response”.

24 Jan 2022

Attenuated tissue immune responses against SARS-CoV-2 in obese and non-obese patients

In a new study, researchers evaluated the single-cell transcriptomes from bronchiolar lavage in three adult cohorts comprising of obese and non-obese SARS-CoV-2 patients.

24 Jan 2022

Investigating Omicron’s fitness and replicative potential compared with earlier SARS-CoV-2 variants using organoids

This study examined the shedding, fitness, and pathogenicity of SARS-CoV-2 VOCs using human airway and alveolar organoids.

24 Jan 2022

Impact of SARS-CoV-2 booster vaccination on Delta variant resurgence in Israel

In a new study, researchers constructed a discrete-time age-of-infection age-stratified transmission model to accurately determine the individual to population-level data on SARS-CoV-2 Delta surge dynamics in Israel

24 Jan 2022

Short- and long-term systemic responses in the golden hamster following SARS-CoV-2 or influenza A virus infection

A group of researchers used the golden hamster as a model system to better understand the long-term impacts of SARS-CoV-2 infection.

24 Jan 2022

Exploring loss of Y chromosome in white blood cells as a risk-factor of life-threatening COVID-19 in men

Researchers published a study exploring the possibilities of predisposing men for a life-threatening disease course of COVID-19.

24 Jan 2022

Impact of clustered mutations in SARS-CoV-2 Omicron spike function

In a new study, researchers explored the characteristics of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant of concern (VOC) Omicron BA.1 sublineage clustered mutations.

24 Jan 2022

Antibody response 18 months after SARS-CoV-2 infection in vaccinated and unvaccinated individuals

A new study assessed the dynamics of IgG titers over 18 months in patients who had recovered from COVID-19 infections during March 2020.

24 Jan 2022

Characterization of unique pathogenesis of SARS-CoV-2 Delta variant in mouse model

Researchers have investigated the pathology and inflammatory response to the Delta variant in mice.

24 Jan 2022

Synthetic estimates of COVID-19 mean incubation time

Researchers provided synthetic estimates of the average incubation time of COVID-19 by using the reports of estimates in the published literature and explored different ways to accommodate heterogeneity involved within these studies.

24 Jan 2022

Human endogenous retrovirus type W envelope protein found to be a biomarker of COVID-19 severity

A new study revealed that the expression of HERV-W envelope protein (ENV) in lymphoid cells from COVID-19 patients correlated with disease outcome making them biomarkers of lymphocyte exhaustion.

24 Jan 2022

Alpaca-derived antibody fragment disrupts interaction between SARS-CoV-2 spike protein and human ACE2

Researchers have been investigating the potential for using nanobodies – special immune particles from llamas and alpacas – against the disease.

24 Jan 2022

Researchers discover mechanism behind SARS-CoV-2 entry into the brain

In a new study, researchers conducted an analysis of databases that have information on the transcriptomic and proteomic expression of ACE2, TMPRSS2, NRP1, and furin in several human brain areas.

24 Jan 2022

Incidence of SARS-CoV-2 infections in orchestra and choir musicians

A new study aimed to study the incidence of SARS-CoV-2 infections in orchestra and choir musicians compared to controls.

24 Jan 2022

Prevalence of olfactory dysfunction 18 months after SARS-CoV-2 infection

Scientists focused on determining the prevalence of OD eighteen months after COVID-19 infection.

24 Jan 2022

Study finds stable T-Cell response against Omicron after mRNA booster vaccination

A new study measured T cell activity in vaccinated individuals and found a third vaccine provided substantial T-cell immunity against the Omicron variant of SARS-CoV-2.

24 Jan 2022

Causal impact of spontaneous relaxation of social distancing practices on spread of SARS-CoV-2 in US

The purpose of a recent study was to examine the causal impact of a spontaneous relaxation of social distancing measures on the spread of SARS-CoV-2.

24 Jan 2022

Research shows depletion of extracellular vesicles weakens immune response towards SARS-CoV-2

Over the past several years, considerable effort has been made towards developing better diagnostic and prognostic tools. However, until now, the focus of research has mainly been on the virus itself or the immune response it triggers. To unify diagnostic and prognostic tools for COVID-19 analyses, researchers propose using extracellular vesicles (EVs) from serum liquid biopsies.

24 Jan 2022

Researchers are in the race to beat Omicron

David Veesler and his lab members aren't getting much sleep these days. In the final weeks of 2021, he and his team worked around the clock to post four coronavirus papers on the preprint server bioRxiv.

24 Jan 2022

SARS News and Research

Researchers examine benefits of lateral flow testing with regards to the new Paxlovid drug for treatment of COVID-19

Study explains why Omicron infections are less likely to cause severe disease

Attenuated tissue immune responses against SARS-CoV-2 in obese and non-obese patients

Investigating Omicron’s fitness and replicative potential compared with earlier SARS-CoV-2 variants using organoids

Impact of SARS-CoV-2 booster vaccination on Delta variant resurgence in Israel

Short- and long-term systemic responses in the golden hamster following SARS-CoV-2 or influenza A virus infection

Exploring loss of Y chromosome in white blood cells as a risk-factor of life-threatening COVID-19 in men

Impact of clustered mutations in SARS-CoV-2 Omicron spike function

Antibody response 18 months after SARS-CoV-2 infection in vaccinated and unvaccinated individuals

Characterization of unique pathogenesis of SARS-CoV-2 Delta variant in mouse model

Synthetic estimates of COVID-19 mean incubation time

Human endogenous retrovirus type W envelope protein found to be a biomarker of COVID-19 severity

Alpaca-derived antibody fragment disrupts interaction between SARS-CoV-2 spike protein and human ACE2

Researchers discover mechanism behind SARS-CoV-2 entry into the brain

Incidence of SARS-CoV-2 infections in orchestra and choir musicians

Prevalence of olfactory dysfunction 18 months after SARS-CoV-2 infection

Study finds stable T-Cell response against Omicron after mRNA booster vaccination

Causal impact of spontaneous relaxation of social distancing practices on spread of SARS-CoV-2 in US

Research shows depletion of extracellular vesicles weakens immune response towards SARS-CoV-2

Researchers are in the race to beat Omicron

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News